Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2

Seo, Y; Mun, CH; Park, SH; Jeon, D; Kim, SJ; Yoon, T; Ko, E; Jo, S; Park, YB; Namkung, W; Lee, SW

Namkung, W (corresponding author), Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon 21983, South Korea.; Lee, SW (corresponding author), Yonsei Univ, Dept Internal Med, Div Rheumatol, Coll Med, Seoul 03722, South Korea.; Lee, SW (corresponding author), Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul 03772, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Interdisciplinary Program Integrated OMICS Biomed, Grad Sch, Seoul 03772, South Korea.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020; 21 (14):

Abstract

Lupus nephritis (LN) is the most frequent phenotype in patients with systemic lupus erythematosus (SLE) and has a high rate of progression to end-stag......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索